4- (azacycloalkyl) -benzene-1, 3 -diol derivatives as tyrosinase inhibitors and their synthesis and use thereof

Details for Australian Patent Application No. 2010329896 (hide)

Owner GALDERMA RESEARCH & DEVELOPMENT

Inventors Boiteau, Jean-Guy; Luzy, Anne-Pascale

Agent Griffith Hack

Pub. Number AU-A-2010329896

PCT Pub. Number WO2011/070080

Priority 0958829 10.12.09 FR; 61/282,064 10.12.09 US

Filing date 8 December 2010

Wipo publication date 16 June 2011

International Classifications

C07D 207/48 Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/451 - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine

A61P 17/00 Drugs for dermatological disorders

C07D 211/96 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

Event Publications

12 July 2012 PCT application entered the National Phase

  PCT publication WO2011/070080 Priority application(s): WO2011/070080

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010329898-Cartridge piston

2010329886-Burner unit for steel making facilities